Tridecapetide having gastrin effect

US4117117A · kind A · utility

Assignee

• Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventor

• Erich Wunsch · Tutzing, DE

Key dates

• Filing date: Jun 21, 1977
• Grant date: Sep 26, 1978
• Expiry date: Jun 21, 1997

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The tridecapeptide having the general formula L-leucyl-L-glutamyl-L-glutamyl-L-glutamyl-L-glutamyl-L-glutamyl-L-alanyl-L -tyrosylglycyl-L-tryptophyl-L-leucyl-L-asparagyl-L-phenylalanineamide, or a salt or protected derivative thereof. Such tridecapeptide has gastrin activity. A process of preparation of such tridecapeptide, a process of use of it, and thereapeutic or diagnostic agents incorporating it.